• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Merck’s EngageZone receives IDG’s CSO Security Award

Merck’s EngageZone receives IDG’s CSO Security Award

December 4, 2014
CenterWatch Staff

EngageZone has been named an honoree of a 2015 CSO50 Award from IDG's CSO. This prestigious honor is awarded to a select group of organizations with security projects that have created outstanding business value and thought leadership for their companies.

Launched in 2013, the CSO50 Awards recognizes 50 organizations for security projects and initiatives that demonstrate outstanding business value and thought leadership. The CSO50 Awards are scored according to a uniform set of criteria by a panel of judges that includes security leaders, industry experts, and academics.

“The EngageZone team is honored to be recognized for our role in developing a secure, compliant, collaborative environment,” said Terry Rice, associate vice president, IT Risk Management and Security and chief security information officer. “Over 700 partners have shared more than 500,000 documents this year alone, with full security assurance and accountability. EngageZone has successfully facilitated innovation and collaboration, streamlined development and costs, and protected the intellectual property of Merck and our extended partner community.”

To enhance enterprise collaboration, Merck envisioned and implemented a cloud based solution that enables the life sciences industry to share information and applications with hundreds of companies without compromising their intellectual property or network security.  

To facilitate this level of multi-organization interaction, EngageZone was jointly developed by Merck and Exostar. EngageZone was built utilizing Exostar’s industry leading Identity and Access Management Solution and control audit framework.  EngageZone provides safety features such as:

  • Single sign-on and access
  • Multi-factor authentication
  • End-to-end encryption, including at-rest and in-transit
  • Multiple levels of access based on security provisioning
  • User/role management and workflow, to support scenarios where privileges change from project-to-project without sacrificing information security or user productivity
  • File sharing and document management to share, review, edit and update documents while maintaining version control.

Through EngageZone, Merck and other life sciences organizations currently are leveraging big data analytics, proprietary applications, multiple databases from access points virtually anywhere in the world, with full accountability and security across the entire community of users.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing